Computational evaluation of novel Schiff base compounds targeting Mycobacterium tuberculosis
Akshata Menasinakai, Pradeepkumar M Ronad, AHM Viswanatha Swamy · 2026
Read Computational evaluation of novel Schiff base compounds targeting Mycobacterium tuberculosis by Akshata Menasinakai, Pradeepkumar M Ronad, AHM Viswanatha Swamy (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13626793.txt.
Description
Menasinakai, Ronad, and Swamy present a 2026 computer study on new Schiff base compounds against tuberculosis. The disease still burdens world health, and its cell wall enzymes offer drug targets. The team designed coumarin-based compounds and docked them in simulation against five such enzymes. Drug-likeness rules and safety screens ran first.
Three compounds, coded SB5, SB13, and SB21, bound well to all five targets. Their grip used hydrogen bonds and greasy contacts at key amino acid spots. Protein shapes were validated before docking, and active sites were mapped. The authors flag the three leads for lab testing as possible anti-tuberculosis candidates. No wet-lab results are claimed yet.
Catalog record
| CREATOR | Akshata Menasinakai, Pradeepkumar M Ronad, AHM Viswanatha Swamy |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 47 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |